ArticleOncoTargets and therapy2021

MiR-17 and miR-93 Promote Tumor Progression by Targeting p21 in Patients with Chordoma.

Wei Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.